Collaboration is an essential part of DNDi’s virtual R&D model: we cannot carry out our work without the engagement of public and private partners.
Today, DNDi has forged a diverse range of alliances and research collaborations with over 200 partners and service providers in nearly 50 countries.
Industry partners and service providers
Loading…
AbbVie
USA

AMG Consultants
UK
Loading…

Anacor Pharmaceuticals (now Pfizer Inc.)
USA

Astellas Pharma Inc.
Japan

AstraZeneca
Sweden

AstraZeneca UK
United Kingdom
Loading…

Basilea Pharmaceutica AG
Switzerland
Loading…

Bayer Healthcare AG
Germany

BioDelivery Sciences International Inc.
USA
Loading…
Loading…

Boehringer Ingelheim
Germany
Loading…

Cambrex (formerly Avista Pharma and SCYNEXIS Inc)
USA
Loading…

Celgene (now Bristol Myers Squibb Inc.)
USA

Charles River Laboratories (formerly WIL Research)
France

Cipla Ltd.
India
Loading…

Daiichi Sankyo
Japan

Daiichi Sankyo RD Novare Co., Ltd.
Japan
Loading…

Dow AgroSciences LLC
USA
Loading…

Eisai Co., Ltd.
Japan

Epichem
Australia
Loading…
Loading…

Eurofarma
Brazil
Loading…

Eurofins CEREP
France
Loading…

Genomics Institute of The Novartis Research Foundation (GNF)
USA
Loading…
Loading…

GlaxoSmithKline (GSK)
UK
Loading…

GlaxoSmithKline (GSK) – Spain
Spain

Instituto Nacional de Laboratorios de Salud (INLASA)
Bolivia
Loading…
Loading…

Intertek